Dublin, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/ks...maceutical ) has announced the addition of the "Biopharmaceutical Contract Manufacturing Market, 2015 - 2025" report to their offering. The Biopharmaceutical Contract Manufacturing Market, 2015 - 2025' report provides an extensive study of the contract manufacturing market for biopharmaceuticals. With biotechnology industry striving to maximize profits, outsourcing has emerged as an ever increasing trend. The study presents an in-depth analysis of a diverse set of biopharmaceutical CMOs on some of the key parameters such as geographical location, scale of operation, type of biologics manufactured, expression systems, type of bioreactors used and fermentation capacity. In addition, it captures some of the potential growth areas which will likely present tremendous opportunities for biopharmaceutical CMOs and ensure an accelerated pace of growth. Some of the niche service areas include manufacturing of ADCs and bispecific antibodies. Specifically, these markets typify huge unmet manufacturing requirements and represent untapped areas of targeted therapy revenue making outsourcing an attractive option. The report assesses the key drivers that have governed the evolution of biopharmaceutical contract manufacturing market over the past several years along with an elaborate discussion on the future trends that will shape the market in the coming years. One of the focus areas of this study is to estimate size of the future opportunity for biopharmaceutical CMOs market over the next decade, segmented on the basis of business operations, type of expression systems and key regions. In addition, the study provides information on some of the most important aspects of biopharmaceutical outsourcing; these include growing collaborations, investment activity, technological advancements and development of biosimilars. In addition to some of the well-known benefits and a promising outlook, the study also highlights considerable challenges currently prevalent in the market. Examples include quality concerns, stringent regulations and lack of funding. Nevertheless, these challenges are paving the way for new strategies and technological improvements, which will indeed be advantageous in the long run. The base year for the report is 2014; the report provides market forecasts for the period 2015 - 2025. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from secondary and primary research. Key Topics Covered: 1. Preface 2. Executive Summary 3. Introduction
4. Biopharmaceutical Contract Manufacturing: Developed Regions 5. Biopharmaceutical Contract Manufacturing: Emerging Regions 6. Competitive Landscape 7. Niche Sectors In Biopharmaceutical Contract Manufacturing 8. Outsourcing Of Biosimilars 9. Recent Developments 10. Market Sizing And Forecast 11. Future Of Biopharmaceutical Cmo Market 12. SWOT Analysis 13. Interview Transcripts 14. Conclusion 15. Appendices 16. List Of Companies - 3P Biopharmaceuticals - AAIPharma Services - ADC Biotechnology - ADC Therapeutics - AERAS - AMYRA - ARMO Biosciences - ATMI - AbGenomics - AbbVie - Ablynx - Active Biotech - AdAlta - Adimab - Affimed - Affinicon - Affinity Life Sciences, Inc. - Affitech - Agennix - Ajinomoto Althea Inc. - Akorn - Aldevron - Alethia Biotherapeutics, Inc. - Alliance Medical Products (Siegfried) - Alligator Bioscience - Allozyne - Alpax Pharmaceuticals - Ambrx - Amega Biotech - Amgen - Antitope Ltd. - Aparna Biosciences Corp. - Apexigen - Apotex Fermentation Inc. - Aptuit - Asahi Glass Company, Ltd. - Aspyrian Therapeutics - AstellasPharma - AstraZeneca - Athera Biotechnologies - AutekBio, Inc. - Avalanche Biotechnologies, Inc - Avecia - Avesta Biotherapeutics and Research - Avid Bioservices, Inc. - AvidBiologics - BIBITEC GmbH - BIOMEVA GmbH - Baliopharm - Barofold - Batavia Bioservices - Bavarian Nordic GmbH - Baxter BioPharma Solutions - Bayer - BeiGene, Co., Ltd. - Beijing ABT Genetic Engineering Technology Co. - Bharat Biotech - Bicycle Therapeutics - Binex Co. Ltd. - Bio Elpida - Bio-Concept - BioConnection - BioGenomics - BioIntermediair - BioLineRx - BioMARC - BioPharmaceuticals Australia - BioReliance - BioSynergy - BioVectra Inc. - BioVolutions - BioXcellence (Boehringer Ingelheim) - Biochemie - Biocon - Bioconvergence - Biogen-Idec - Biomay AG - Biopharmaceutical Development Program - Frederick National Laboratory for Cancer Research (FNLCR) - Biotechnique - Biotechpharma UAB - Biotecnol - Biotest - Biovest International - Biovian Ltd. - Biowa - Blue Stream Laboratories - Bristol Myers Squibb - CEVEC Pharmaceuticals - CEVEC Pharmaceuticals - CMC Biologics - CSIRO - Cantab Biopharmaceuticals Ltd - Carbogen Amcis - Catalent - Celgene - Celladon - Celladon Corporation - Cellca GmbH - Celldex - Cellectis - Cellitron - Celltech Biologics - Cellular Therapeutics Ltd. - Celonic AG - Center for Biocatalysis and Bioprocessing, The University of Iowa - Center for Cell & Gene Therapy - Center of iPS Cell Research and Application at Kyoto University in Japan - Cerbios Pharma - Charles River Laboratories - ChemPartner - Cobra Biologics - Cognate BioServices - Concord Biotech Limited - ContraFect Corporation - Cook Pharmica LLC - Corning BioPro - Covance, Inc. - Creative Biolabs - Cytovance Biologics, Inc. - DM Bio (Dong-A meiji) - DSM Pharmaceutical Products - Daiichi Sankyo - Dalton Pharma Services - Damon Biotech - Development Center for Biotechnology, Taiwan - Diamedica Incorporated - Dutalys - EMD Serono - Eclipse - Elan plc - Eli Lilly - Emergent Biosolutions - Endo Pharmaceuticals - Endo Pharmaceuticals USA - Enteris Biopharma - Epigen Biotech - Esperance Pharmaceuticals - Eucodis Bioscience - Eurofins Central Global Laboratory - Eurogentec Biologics - Evocatal - Evolva Holding - F-star - Fabion Pharmaceuticals - Five Prime Therapeutics, Inc. - Florida Biologix - Formatech, Inc. - Foundation BioPharma - Foundation BioPharma, Inc - French National Centre for Scientific Research - Université de Toulouse - Frontage Laboratories, Inc. - Fujifilm Diosynth Biotechnologies - Fujirebio Europe B.V. - Fusimab - Gala Biotech (Catalent subsidiary) - Gallus BioPharmaceuticals - Ganymed Pharmaceuticals - Genentech - Genhelix (Mabxience group) - Genmab - Gilead - GlaxoSmithKline Biopharmaceuticals - Glenmark Pharmaceuticals - GlycoVaxyn AG - Glycotope Group - Goodwin Biotechnology, Inc. - Grand River Aseptic Manufacturing - Great Ormond Street Hospital - HALIX - Harvest Moon - Heidelberg Pharma - Hisun Pharmaceuticals USA - Ho Research Consortium - Hong Kong Institute of Biotechnology - Hospira One 2 One - Hyglos GmbH - IDDI - IDT Biologika GmbH - IMMUNE Pharmaceutical - IMMUNE Pharmaceutical - INC Research, LLC - INVISTA - ImClone Systems - ImmuneMed, Inc - Immunogen - Immunomedics - Immutep - Index Ventures, LLP - Inhibrx - Inno Biologics Sdn. Bhd. - Innovent Biologics, Inc. - Insmed Inc. - Inspiration Biopharmaeuticals - Institute of Immunology - Intas Pharmaceuticals - Integrity Bio - Intellect Neurosciences - International Joint Cancer Institute - Intertek - Irvine Pharmaceutical Services - JRS - KABS Pharmaceutic Services - KBI BioPharma, Inc. - KalonBiotherpeutics - Kane Biotech Inc. - Kemwell Biopharma Pvt Ltd - King's College London - Kite Pharma - LFB Biomanufacturing - LFB Biomedicaments - Lampire Biological Laboratories - LegoChem - Lentigen Corporation - Lindis Biotech - Lonza - Louisiana Gene Therapy Research Consortium - Lyophilization Services of New England. - MBI International - MD Anderson Cancer Center - MGC Pharma - MODA Technology Partners - MPI Research - Mabion - MacroGenics - Maine Biotechnology Services, Inc. - Mass Biologics - MedImmune - MediaPharma - Medicago - Menarini Biotech S.r.l. - Merck - Merck Millipore - Meridian Life Science, Inc. - Merrimack - Mersana - Merus - Mesoblast Limited - MicrobixBiosystemsinc. - Military Medical University - Millennium - Millennium Pharmaceuticals, Inc. - MiltenyiBiotec - Minomic International Ltd. - Molecular Partners AG - MorphoSys - Mycenax Biotech - NHS Blood and Transplant - Nabi Biopharamaceuticals - Nabi Biopharmaceuticals - Nascent Biologics, Inc. - National Research Council Canada - Nature Technology Corporation - Neuland Laboratories Limited - NextarChempharma Ltd. - Nicholas laboratories - Norwegian Institute of Public Health - NovImmune - Nova Laboratories Ltd. - Novacep Biopharmaceutical - Novartis - Novasep - Novozyme - Novozymes Biopharma - Numab - Oasmia Pharmaceutical - Octoplus - Omnia Biologics - OncoMax - OncoMed - OncoMed Pharmaceutical, Inc. - OncoSynergy - Orexigen - OsoBio (AMRI) - Oxford BioTherapeutics - PX' Therapeutics - PacificGMP - Paktis Antibody Services GmbH - Pamlico Biopharma Inc. - Paragon Bioservices - Parexel - Pasteuria Bioscience - Patheon (unit of DPx Holdings) - Pfizer - Pfizer CentreSource - PharmAbcine - PharmaSynth - Pharmacyclics - PharmedArtis GmbH - Philochem - Phyton Biotech - Piramal Pharma Solutions - Plasmid Factory - Polymun Scientific - Precision Biologics - Premas Biotech - ProBioGen AG - Progenics - Progenitor Cell Therapy, LLC - Promab Biotechnologies Inc. - Protheragen - ProvantageBiodevelopment Center - Puresyn - Pyramid Labs - QuaDPharma, LLC - Quintiles - Receptor Logic - Redwood Bioscience Inc, - Regeneron Pharmaceuticals - Reliance Life Sciences - RentschlerBiotechnologie GmbH - RheinMinapharm - Richter-HELM Biotec GmbH - Roche - RuiYi Inc. - SAFC Inc - SGS Life Science Services - SICOR Biotech UAB (Teva) - Samsung Biologics - Sandoz - Sanofi Aventis - Sanofi CEPiA - Sanofi-Aventis' Recherche and Development - Sanquin Pharmaceutical Servives - Sartorius Stedium biotech - Scil Proteins - Scripps Research Institute - Sea Lane Biotechnologies - Seattle Genetics - Selexys Pharmaceuticals Corp. - Serina Therapeutics - Shasun - Sorrento Therapeutics - Statens Serum Institut (only API) - StemCentrx - Sumitra Pharmaceuticals - Sutro Biopharma - Symbiosis Pharmaceutical Services - Symbiosis, the Analytical Company - SynCo Bio Partners - Synergys Biotherapeutics - Syngene - Synimmune - Sypharma Pty Ltd - Takeda - The National Institutes for Health Center for Regenerative Medicine - The National Institutes of health Center for Regenerative Medicine - Therapure Biopharma Inc. - Thermo Fisher Scientific - Toyobo Biologics, Inc. - Toyota Tsusho Corporation - Translational Sciences, Inc. - Transporin - Trion - Trion Pharma - UCB - UMN Pharma Inc. - UMN Pharma Inc. - University of Copenhagen - University of Nebraska - Biological Process Development Facility - University of Oxford Clinical BioManufacturingFacility - VGXI Inc. - VGXI, Inc. - Valerion Therapeutics - Vecura - Vetter Pharma International GmbH - Vibalogics - Virdante Pharmaceuticals - Vista Biologicals Corp. - Vivalis SA - Vivante GMP Solutions - Viventia - Voyager Therapeutics - WIL Research - WRAIR Pilot Bioproduction Facility - Wacker Biotech GmbH - WaismanBiomanufacturing - Walter Reed Pilot Biproduction facility - Wockhardt Limited - WuXiApptec, Inc. - XL-Protein - Xcelience - Xencor - Xoma Corporation - Zhejiang HISUN Pharmaceuticals Co. Ltd. - Zhejiang Medicine Co. - ZydusCadila - Zymeworks - ZymoGenetics - Zyngenia For more information visit http://www.researchandmarkets.com/research/ks...maceutical
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Biopharmaceuticals
